Nyt fra tidsskrifterne
Søgeord (hepatitis) valgt.
319 emner vises.
-
Prevalence and genotype distribution of human papillomavirus (HPV) in an at-risk and suspected population in IranBMC Infectious DiseasesTilføjet 18. maj 2026
-
Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol, Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocolBMJ OpenTilføjet 18. maj 2026
-
Revisiting the natural history of Jorge Lobo’s disease: a mycological enigma spanning unresolved taxonomy, uncertain transmission, and inadequate therapy, Revisiting the natural history of Jorge Lobo’s disease: a mycological enigma spanning unresolved taxonomy, uncertain transmission, and inadequate therapyClinical Microbiology ReviewsTilføjet 18. maj 2026
-
Impact of semaglutide on liver fibrosis score in people with HIV: findings from the CNICS cohortAIDSTilføjet 18. maj 2026
-
Global burden and forecast of acute viral hepatitis B among women of childbearing age: a systematic analysis of the global burden of disease study 2021BMC Infectious DiseasesTilføjet 17. maj 2026
-
A Multicenter, Open-Label, Randomized, Non-Inferiority Trial of 8 Versus 12 Weeks of Sofosbuvir/Ravidasvir Treatment in Non-Cirrhotic Patients with Chronic Hepatitis C Virus Infection (EASE Trial), A Multicenter, Open-Label, Randomized, Non-Inferiority Trial of 8 Versus 12 Weeks of Sofosbuvir/Ravidasvir Treatment in Non-Cirrhotic Patients with Chronic Hepatitis C Virus Infection (EASE Trial)International Journal of Infectious DiseasesTilføjet 16. maj 2026
-
Prevalence of HIV and hepatitis B co-infection in Nigeria: a systematic review and meta-analysisBMC Infectious DiseasesTilføjet 15. maj 2026
-
Uncovering core stemness biomarkers in HBV-HCC through integrated multi-omicsPLoS One Infectious DiseasesTilføjet 14. maj 2026
-
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)Clinical Infectious DiseasesTilføjet 13. maj 2026
-
Concerns regarding the probabilistic sensitivity analysis in the cost-effectiveness of universal hepatitis delta virus testingClinical Infectious DiseasesTilføjet 13. maj 2026
-
Clinical characteristics of sporadic acute Q fever diagnosed by metagenomic next-generation sequencing: a retrospective analysis and literature review in ChinaBMC Infectious DiseasesTilføjet 13. maj 2026
-
Hidden burden of hepatitis B: occult HBV infection in vaccinated offspring of HBsAg-positive mothers in an endemic areaBMC Infectious DiseasesTilføjet 13. maj 2026
-
Developing a Preterm Birth Prediction Model in Pregnant People with HIV using a Population-Based CohortJournal of Acquired Immune Deficiency SyndromesTilføjet 13. maj 2026
-
Hepatitis B and C Prevention, Screening and Diagnostic Services at HIV Treatment Sites: International epidemiology Databases to Evaluate AIDSJournal of Acquired Immune Deficiency SyndromesTilføjet 13. maj 2026
-
Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current DefinitionsClinical Infectious DiseasesTilføjet 12. maj 2026
-
Application of machine-learning algorithms to identify the key determinants of risk for HIV, hepatitis C and hepatitis B in primary care settingsBMC Infectious DiseasesTilføjet 11. maj 2026
-
Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA Management, Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA ManagementJournal of Medical VirologyTilføjet 10. maj 2026
-
A Comparative Study of Entecavir and Tenofovir Alafenamide on Quantitative HBsAg Reduction in Patients With CHB, A Comparative Study of Entecavir and Tenofovir Alafenamide on Quantitative HBsAg Reduction in Patients With CHBJournal of Medical VirologyTilføjet 10. maj 2026
-
The curious case of aplastic anemia: a fatal triple co-infection with Aspergillus, Mucorales, and NocardiaBMC Infectious DiseasesTilføjet 10. maj 2026
-
Determinants of blood transfusion-transmitted infections in donated bloodBMC Infectious DiseasesTilføjet 10. maj 2026
-
Modeling predicts shortening of DAA treatment duration to 5 weeks in individuals with recent or chronic infection with HCV RNA negativity at day 7 on treatmentJournal of Infectious DiseasesTilføjet 9. maj 2026
-
Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High‐Replicative Low‐Inflammatory Phase: A 48‐Week Randomized Controlled Trial, Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High‐Replicative Low‐Inflammatory Phase: A 48‐Week Randomized Controlled TrialJournal of Medical VirologyTilføjet 8. maj 2026
-
Prevalence of anti-HBc and anti-HBs among blood donors in Guangzhou: implications for HBV screening strategies in ChinaBMC Infectious DiseasesTilføjet 8. maj 2026
-
The Paradox of Progress: A Field Epidemiologist’s Tale of Hepatitis A in TransitionAmerican Journal of Tropical Medicine and HygieneTilføjet 7. maj 2026
-
LINC01012 Drives Hepatitis B‐Related Hepatocellular Carcinoma Progression Through HNRNPL‐Mediated Stabilization of Serine/Threonine‐Protein Kinase‐S, LINC01012 Drives Hepatitis B‐Related Hepatocellular Carcinoma Progression Through HNRNPL‐Mediated Stabilization of Serine/Threonine‐Protein Kinase‐SJournal of Medical VirologyTilføjet 6. maj 2026
-
Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in Mice, Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in MiceJournal of Medical VirologyTilføjet 6. maj 2026
-
National Prescribing Trends of Direct-Acting Antivirals for Hepatitis CJAMATilføjet 6. maj 2026
-
Psychosocial predictors of Hepatitis B testing intentions among non -pregnant women of reproductive age in rural Ghana: a Theory of Planned Behaviour approachBMC Infectious DiseasesTilføjet 4. maj 2026
-
Local insights into hepatitis B Virus: genotype distribution and clinical profiles among HIV/HBV co-infected patients in Maputo, MozambiqueBMC Infectious DiseasesTilføjet 4. maj 2026
-
Seroprevalence, vaccination coverage and associated factors of hepatitis B and C infections among pregnant women in Azare, Bauchi State, Northeast NigeriaBMC Infectious DiseasesTilføjet 4. maj 2026
-
Hepatitis B vaccine uptake, completion, and associated factors among university students in Tanzania: a mixed method study at KCMC University, Moshi, TanzaniaBMC Infectious DiseasesTilføjet 4. maj 2026
-
Sexually transmitted infections screening in the emergency department is feasible, but is it efficient ?Current Opinion in Critical CareTilføjet 2. maj 2026
-
Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block, Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry blockProceedings of the National Academy of SciencesTilføjet 2. maj 2026
-
Schistosoma mansoni Infections Are Associated With Fecal Calprotectin Markers of Gut Inflammation After Accounting for HIV, Hepatitis B, and MalariaJournal of Infectious DiseasesTilføjet 2. maj 2026
-
Impact of flooding events on waterborne and vector-borne infections: a systematic reviewBMC Infectious DiseasesTilføjet 29. april 2026
-
Hepatitis B burden in the Middle East and North Africa region, 1990–2030: trends, projections, and age–period–cohort analysisBMC Infectious DiseasesTilføjet 29. april 2026
-
A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis, A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitisNature MedicineTilføjet 29. april 2026
-
Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018Clinical Infectious DiseasesTilføjet 27. april 2026
-
Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern California, Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern CaliforniaJournal of Medical VirologyTilføjet 24. april 2026
-
Hepatitis B Vaccine Series Completion by 18 Months in Infants Without a Birth DoseJAMA Network Open New OnlineTilføjet 24. april 2026
-
A new hepatitis delta virus hotspot in Ethiopia: a multicenter study, A new hepatitis delta virus hotspot in Ethiopia: a multicenter studyInternational Journal of Infectious DiseasesTilføjet 22. april 2026
-
Prevalence and risk factors of hepatitis B and C viral infections among pregnant women attending antenatal clinic in Sekondi-Takoradi Metropolis, Western Region of GhanaBMC Infectious DiseasesTilføjet 22. april 2026
-
Chronic Hepatitis B in Children Admitted to a Tertiary Hospital in Türkiye: A 23‐Year Observational Study, Chronic Hepatitis B in Children Admitted to a Tertiary Hospital in Türkiye: A 23‐Year Observational StudyJournal of Medical VirologyTilføjet 22. april 2026
-
Epidemiologic Incentive to Eliminate Hepatitis C Virus in More ChildrenJAMA Network Open New OnlineTilføjet 19. april 2026
-
Hepatitis C Virus Testing in Perinatally Exposed ChildrenJAMA Network Open New OnlineTilføjet 19. april 2026
-
Diagnostic Accuracy, Satisfaction, and Acceptability of Point-of-Care Testing for Syphilis, Hepatitis B, and Hepatitis C Infections among Thai Adolescents and Young Adults with Sexual Risk Behaviors, Diagnostic Accuracy, Satisfaction, and Acceptability of Point-of-Care Testing for Syphilis, Hepatitis B, and Hepatitis C Infections among Thai Adolescents and Young Adults with Sexual Risk BehaviorsInternational Journal of Infectious DiseasesTilføjet 18. april 2026
-
Point-of-Care Hepatitis C Testing in a Tribal SettingJAMA Network Open New OnlineTilføjet 17. april 2026
-
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVAIDSTilføjet 15. april 2026
-
HIV–sex interaction effect on risk of hepatitis C–related cirrhosis, decompensation, and hepatocellular carcinomaAIDSTilføjet 15. april 2026
-
Rapid HCV diagnostics: aligning molecular innovation with real-world elimination needsJournal of Infectious DiseasesTilføjet 10. april 2026